Rhinovirus infections drug market to reach $2.05 billion by 2030 at 8.6% CAGR, driven by increasing incidence of respiratory disorders.
Read More
Rheumatology therapeutics market to reach $54.16 billion by 2030 at 4.1% CAGR, driven by rising prevalence of autoimmune diseases.
Read MoreRheumatoid arthritis drugs market to reach $67.49 billion by 2030 at 2.5% CAGR, driven by growing elderly population.
Read More
Retinal disorder treatment market to reach $21.27 billion by 2030 at 9.4% CAGR, driven by increasing prevalence of diabetes.
Read MoreRetinal biologics market to reach $49.03 billion by 2030 at 11.9% CAGR, driven by rising demand for personalized medicine.
Read More
Respules market to reach $2.94 billion by 2030 at 9.1% CAGR, driven by rise in incidence of respiratory disorders and rising healthcare expenditure.
Read More
Respiratory syncytial virus fusion inhibitors market to reach $3.17 billion by 2030 at 16.5% CAGR, driven by growing incidence of respiratory infections and increasing healthcare expenditure.
Read More
Respiratory disease vaccine market to reach $81 billion by 2030 at 3.2% CAGR, driven by rising incidence of tuberculosis.
Read More
The global respiratory biologics market to reach $15.66 billion by 2030 at 16.1% CAGR, driven by rise in air pollution.
Read More
Research-grade proteins market to reach $3.19 billion by 2030 at 18.6% CAGR, driven by growing number of clinical trials.
Read More